Cancer is not just one disease, but a large group of almost one hundred diseases. Its two main characteristics are uncontrolled growth of the cells in the human body and the ability of these cells to migrate from the original site and spread to distant sites. If the spread is not controlled, cancer can result in death.
Scientists uncover new key to the puzzle of hormone therapy and breast cancer – The decreased use of postmenopausal hormone therapy has played a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer, revealed by researchers.
Breast density associated with increased risk of cancer recurrence — Study finds higher risk of cancer recurrence in women with dense breasts. – Women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts, revealed by researchers in a study published in the Cancer — journal of the American Cancer Society.
New finding suggests prostate biopsy is not always necessary – Elevated prostate specific antigen (PSA) levels in men may be caused by a hormone normally occurring in the body, and are not necessarily a predictor of the need for a prostate biopsy, revealed by researchers.
Study spotlights efficacy of questionnaire to identify patients at high risk for lung cancer — Asking a few questions can help determine risk for lung cancer – Aa simple questionnaire designed to identify patients at high risk of lung cancer is found helpful. The new study is featured in the November issue of the Journal of Thoracic Oncology.
Study finds delay in follow-up among African-American women receiving abnormal breast finding – African-American women face obstacles to receive appropriate breast cancer?related care in US. There is a significant delay in follow-up times among African-American women after the finding of a suspicious breast abnormality.
Pitt/NIH team find way to protect healthy cells from radiation damage – Researchers have found a way to not only protect healthy tissue from the toxic effects of radiation treatment, but also increase tumor death. The findings appear today in Science Translational Medicine.
Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for FUSILEV(R) in Advanced Metastatic Colorectal Cancer – A Complete Response letter is issued by the U.S. Food and Drug Administration (FDA) regarding the supplemental New Drug Application (sNDA) for FUSILEV (levoleucovorin) for injection for treatment of patients with advanced metastatic colorectal cancer.
Major breast cancer breakthrough announced at BC Cancer Agency — BC scientists first in world to decode genetic evolution of a breast cancer tumour. – Canadian researchers have decoded all of the three billion letters in the DNA sequence of a metastatic lobular breast cancer tumor, a type of breast cancer which accounts for about 10 per cent of all breast cancers.
Recent, vigorous exercise is associated with reduced breast cancer risk – Post-menopausal women who engage in moderate to vigorous exercise and physical activity have a reduced risk of breast cancer, revealed by researchers. Breast cancer is recognized as the most common cancer affecting US women.
Women fare better than men with metastatic colorectal cancer — are hormones helping? – Younger women with metastatic colorectal cancer lived longer than younger men, revealed by researchers in a new US study. However, this survival advantage disappeared with age, suggesting a benefit from estrogen or other hormones.
Lack of social interaction affects health outcomes of breast cancer — social isolation increases the mortality risk from several chronic diseases. – Social environment can play an important role in the biology of disease, including breast cancer, and lead to significant differences in health outcome, revealed by researchers.
Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy – For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug to treat the disease.
